If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

RLAY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.43%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,282,949.55

Relay Therapeutics Insider Trading History Chart

Relay Therapeutics Share Price & Price History

^$15.31

▼ -0.17 (-1.10%)

As of 03/24/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Relay Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/8/2023	Sanjiv Patel	CEO	Sell	14,000	$20.98	$293,720.00
1/30/2023	Peter Rahmer	Insider	Sell	740	$21.56	$15,954.40	158,540
1/30/2023	Thomas Catinazzo	CFO	Sell	864	$21.56	$18,627.84	150,482
1/18/2023	Sanjiv Patel	CEO	Sell	28,000	$20.87	$584,360.00	254,554
1/12/2023	Brian Adams	Insider	Sell	9,994	$20.00	$199,880.00	51,531
12/27/2022	Donald A. Bergstrom	Insider	Sell	980	$14.49	$14,200.20	85,886
12/27/2022	Thomas Catinazzo	CFO	Sell	445	$14.49	$6,448.05	50,231
11/10/2022	Sanjiv Patel	CEO	Sell	28,000	$20.00	$560,000.00	254,554
11/8/2022	Sanjiv Patel	CEO	Sell	14,000	$20.18	$282,520.00	254,554
11/1/2022	Donald A. Bergstrom	Insider	Sell	8,000	$22.75	$182,000.00	86,866
10/28/2022	Andy Porter	Insider	Sell	448	$21.54	$9,649.92	45,164
10/28/2022	Thomas Catinazzo	CFO	Sell	1,099	$21.54	$23,672.46	50,676
10/12/2022	Sanjiv Patel	CEO	Sell	14,000	$21.18	$296,520.00	254,554
10/3/2022	Donald A. Bergstrom	Insider	Sell	8,000	$22.43	$179,440.00	88,683
9/27/2022	Brian Adams	Insider	Sell	294	$22.73	$6,682.62	62,548
9/27/2022	Thomas Catinazzo	CFO	Sell	443	$22.73	$10,069.39	51,775
9/14/2022	Sanjiv Patel	CEO	Sell	14,000	$23.47	$328,580.00	254,554
9/8/2022	Mark Murcko	Director	Sell	25,000	$29.95	$748,750.00	996,952
9/8/2022	Thomas Catinazzo	CFO	Sell	26,257	$30.00	$787,710.00	52,218
8/24/2022	Donald A. Bergstrom	Insider	Sell	15,000	$25.00	$375,000.00	89,659
8/5/2022	Donald A. Bergstrom	Insider	Sell	8,000	$20.00	$160,000.00	89,659
7/28/2022	Andy Porter	Insider	Sell	452	$21.27	$9,614.04	45,871
7/28/2022	Thomas Catinazzo	CFO	Sell	734	$21.26	$15,604.84	52,218
7/6/2022	Donald A. Bergstrom	Insider	Sell	8,000	$20.00	$160,000.00	91,494
6/27/2022	Andy Porter	Insider	Sell	265	$20.31	$5,382.15	46,323
6/27/2022	Thomas Catinazzo	CFO	Sell	300	$20.31	$6,093.00	52,952
6/24/2022	Donald A. Bergstrom	Insider	Sell	8,000	$20.00	$160,000.00	92,493
5/2/2022	Donald A. Bergstrom	Insider	Sell	13,000	$24.62	$320,060.00	92,493
4/28/2022	Donald A. Bergstrom	Insider	Sell	1,811	$25.57	$46,307.27	92,493
4/28/2022	Thomas Catinazzo	CFO	Sell	725	$25.57	$18,538.25	53,252
4/13/2022	Sanjiv Patel	CEO	Sell	28,000	$31.95	$894,600.00	253,740
4/1/2022	Donald A. Bergstrom	Insider	Sell	18,000	$30.32	$545,760.00	94,304
3/29/2022	Andy Porter	Insider	Sell	294	$29.87	$8,781.78
3/29/2022	Thomas Catinazzo	CFO	Sell	282	$29.87	$8,423.34
3/24/2022	Donald A. Bergstrom	Insider	Sell	10,000	$30.00	$300,000.00
3/24/2022	Thomas Catinazzo	CFO	Sell	13,286	$30.00	$398,580.00
3/10/2022	Donald A. Bergstrom	Insider	Sell	10,000	$25.00	$250,000.00
3/1/2022	Donald A. Bergstrom	Insider	Sell	8,000	$23.88	$191,040.00
2/22/2022	Donald A. Bergstrom	Insider	Sell	22,994	$20.94	$481,494.36
12/27/2021	Andy Porter	Insider	Sell	260	$33.10	$8,606.00
12/27/2021	Thomas Catinazzo	SVP	Sell	295	$33.10	$9,764.50
11/15/2021	Brian Adams	General Counsel	Sell	6,500	$35.42	$230,230.00
11/15/2021	Thomas Catinazzo	SVP	Sell	22,500	$35.40	$796,500.00
10/15/2021	Donald A. Bergstrom	Insider	Sell	30,000	$34.15	$1,024,500.00
9/27/2021	Donald A. Bergstrom	Insider	Sell	646	$36.87	$23,818.02
9/27/2021	Thomas Catinazzo	SVP	Sell	293	$36.87	$10,802.91
9/13/2021	Brian Adams	General Counsel	Sell	6,500	$35.02	$227,630.00	32,077
9/13/2021	Thomas Catinazzo	SVP	Sell	22,500	$35.00	$787,500.00	38,077
6/16/2021	Donald A. Bergstrom	Insider	Sell	42,242	$33.75	$1,425,667.50	119,483
6/7/2021	Brian Adams	General Counsel	Sell	6,500	$35.00	$227,500.00	32,370
6/7/2021	Thomas Catinazzo	SVP	Sell	22,500	$35.00	$787,500.00	38,370
4/26/2021	Brian Adams	General Counsel	Sell	6,500	$35.00	$227,500.00	32,370
4/16/2021	Donald A. Bergstrom	Insider	Sell	56,324	$32.36	$1,822,644.64	77,241
1/28/2021	Brian Adams	General Counsel	Sell	5,000	$55.05	$275,250.00	15,000
1/14/2021	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	1,965,294	$41.00	$80,577,054.00
1/12/2021	Rock Ventures Iii L.P. Third	Major Shareholder	Sell	1,500,000	$40.00	$60,000,000.00

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Relay Therapeutics (NASDAQ:RLAY)

Institutional Buying and Selling by Quarter

Relay Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/23/2023	ETF Managers Group LLC	10,453	$0.16M	0.0%	N/A	0.009%
3/23/2023	MetLife Investment Management LLC	44,634	$0.67M	0.0%	+9.4%	0.037%
2/28/2023	Voya Investment Management LLC	102,176	$1.53M	0.0%	+3.2%	0.084%
2/16/2023	Alliancebernstein L.P.	1,690,021	$25.25M	0.0%	+20.4%	1.398%
2/15/2023	Metropolitan Life Insurance Co NY	5,264	$79K	0.0%	+15.5%	0.004%
2/15/2023	MetLife Investment Management LLC	44,634	$0.67M	0.0%	+9.4%	0.037%
2/15/2023	Capital Impact Advisors LLC	16,428	$0.25M	0.2%	+7.4%	0.014%
2/15/2023	State of Wisconsin Investment Board	76,145	$1.14M	0.0%	+10.6%	0.063%
2/15/2023	Schonfeld Strategic Advisors LLC	23,603	$0.35M	0.0%	+9.0%	0.020%
2/15/2023	Squarepoint Ops LLC	13,904	$0.21M	0.0%	-64.5%	0.012%
2/15/2023	T. Rowe Price Investment Management Inc.	2,006,541	$29.98M	0.0%	+10.8%	1.660%
2/15/2023	Legal & General Group Plc	62,334	$0.93M	0.0%	-1.4%	0.052%
2/15/2023	Morgan Stanley	2,369,344	$35.40M	0.0%	+592.1%	1.960%
2/15/2023	Norges Bank	1,788,323	$26.72M	0.0%	N/A	1.479%
2/15/2023	Delphia USA Inc.	12,199	$0.18M	0.2%	N/A	0.010%
2/15/2023	E Fund Management Co. Ltd.	24,680	$0.37M	0.0%	+83.0%	0.020%
2/15/2023	Gilder Gagnon Howe & Co. LLC	107,958	$1.61M	0.0%	-24.8%	0.089%
2/15/2023	Algert Global LLC	75,691	$1.13M	0.1%	N/A	0.063%
2/15/2023	ArrowMark Colorado Holdings LLC	2,686,711	$40.14M	0.5%	+6.9%	2.222%
2/14/2023	Price T Rowe Associates Inc. MD	4,493,004	$67.13M	0.0%	-1.5%	3.717%
2/14/2023	Engineers Gate Manager LP	35,085	$0.52M	0.0%	N/A	0.029%
2/14/2023	Driehaus Capital Management LLC	1,618,353	$24.18M	0.4%	-45.5%	1.339%
2/13/2023	Charles Schwab Investment Management Inc.	654,443	$9.78M	0.0%	+5.7%	0.541%
2/13/2023	Deutsche Bank AG	236,964	$3.54M	0.0%	-39.3%	0.196%
2/13/2023	Barclays PLC	271,839	$4.06M	0.0%	+81.0%	0.225%
2/13/2023	Renaissance Technologies LLC	60,800	$0.91M	0.0%	N/A	0.050%
2/13/2023	The Manufacturers Life Insurance Company	106,333	$1.58M	0.0%	+3.1%	0.088%
2/13/2023	ExodusPoint Capital Management LP	104,736	$1.57M	0.0%	N/A	0.087%
2/13/2023	Credit Suisse AG	76,116	$1.14M	0.0%	+18.0%	0.063%
2/13/2023	Geode Capital Management LLC	1,694,121	$25.31M	0.0%	+9.2%	1.401%
2/13/2023	Finepoint Capital LP	714,848	$10.68M	3.5%	N/A	0.591%
2/13/2023	JPMorgan Chase & Co.	4,469,898	$66.78M	0.0%	-10.9%	3.697%
2/13/2023	Rhenman & Partners Asset Management AB	200,000	$2.99M	0.3%	N/A	0.165%
2/10/2023	Bank of America Corp DE	354,489	$5.30M	0.0%	+133.2%	0.293%
2/10/2023	American International Group Inc.	40,263	$0.60M	0.0%	+10.9%	0.033%
2/10/2023	Amalgamated Bank	11,322	$0.17M	0.0%	+13.4%	0.009%
2/10/2023	Schroder Investment Management Group	238,242	$3.56M	0.0%	+61.4%	0.197%
2/10/2023	AXQ Capital LP	19,304	$0.29M	0.2%	N/A	0.016%
2/10/2023	Victory Capital Management Inc.	45,560	$0.68M	0.0%	-32.1%	0.038%
2/10/2023	CI Investments Inc.	2,932	$44K	0.0%	N/A	0.002%
2/10/2023	Artisan Partners Limited Partnership	295,454	$4.41M	0.0%	-3.3%	0.244%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	40,061	$0.60M	0.0%	+15.2%	0.033%
2/9/2023	First Trust Advisors LP	13,234	$0.20M	0.0%	-80.4%	0.011%
2/9/2023	Victory Capital Management Inc.	55,077	$0.89M	0.0%	-18.0%	0.046%
2/9/2023	Dimensional Fund Advisors LP	1,058,543	$15.81M	0.0%	+66.5%	0.876%
2/9/2023	Principal Financial Group Inc.	23,688	$0.35M	0.0%	+14.7%	0.020%
2/9/2023	Citigroup Inc.	209,240	$3.13M	0.0%	+15.1%	0.173%
2/8/2023	UBS Group AG	263,100	$3.93M	0.0%	+1,188.1%	0.218%
2/8/2023	Swiss National Bank	188,700	$2.82M	0.0%	+2.1%	0.156%
2/8/2023	Arizona State Retirement System	22,050	$0.33M	0.0%	+24.5%	0.018%
2/7/2023	State Board of Administration of Florida Retirement System	25,217	$0.38M	0.0%	-22.2%	0.021%
2/7/2023	Handelsbanken Fonder AB	23,500	$0.35M	0.0%	N/A	0.019%
2/7/2023	TD Asset Management Inc	123,562	$1.85M	0.0%	+3.5%	0.102%
2/2/2023	Intellectus Partners LLC	28,785	$0.43M	0.1%	+10.8%	0.024%
2/2/2023	SG Americas Securities LLC	17,450	$0.26M	0.0%	+43.6%	0.014%
2/2/2023	ProShare Advisors LLC	20,950	$0.31M	0.0%	+19.1%	0.017%
2/2/2023	Monarch Partners Asset Management LLC	85,139	$1.27M	0.4%	+100.0%	0.070%
2/1/2023	State of New Jersey Common Pension Fund D	124,496	$1.86M	0.0%	+34.9%	0.103%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	12,420	$0.19M	0.0%	+20.1%	0.010%
1/24/2023	Baillie Gifford & Co.	414,522	$6.19M	0.0%	+2.4%	0.341%
12/8/2022	Bank of New York Mellon Corp	342,252	$7.66M	0.0%	+15.0%	0.283%
11/22/2022	Capital Impact Advisors LLC	15,303	$0.28M	0.3%	+19.2%	0.013%
11/21/2022	California State Teachers Retirement System	97,342	$2.18M	0.0%	+10.6%	0.081%
11/17/2022	M&T Bank Corp	23,200	$0.52M	0.0%	-14.4%	0.019%
11/16/2022	Alphabet Inc.	1,568,753	$35.09M	1.8%	N/A	1.298%
11/16/2022	Sandia Investment Management LP	5,908	$0.13M	0.0%	N/A	0.005%
11/16/2022	BNP Paribas Arbitrage SNC	103,147	$2.31M	0.0%	N/A	0.085%
11/15/2022	Alliancebernstein L.P.	1,403,425	$31.40M	0.0%	-25.1%	1.161%
11/15/2022	State Street Corp	3,668,070	$82.06M	0.0%	-23.2%	3.034%
11/15/2022	Twinbeech Capital LP	22,518	$0.50M	0.0%	N/A	0.019%
11/15/2022	Two Sigma Advisers LP	19,500	$0.44M	0.0%	N/A	0.016%
11/15/2022	UBS Asset Management Americas Inc.	829,560	$18.56M	0.0%	+6.1%	0.686%
11/15/2022	Vanguard Group Inc.	8,359,520	$187M	0.0%	+17.8%	6.915%
11/15/2022	Price T Rowe Associates Inc. MD	4,561,363	$102.04M	0.0%	-13.9%	3.773%
11/15/2022	Putnam Investments LLC	60,418	$1.35M	0.0%	-1.8%	0.050%
11/15/2022	EcoR1 Capital LLC	4,163,824	$93.15M	2.7%	+11.8%	3.444%
11/15/2022	Ensign Peak Advisors Inc	16,870	$0.38M	0.0%	+262.0%	0.014%
11/15/2022	First Trust Advisors LP	67,397	$1.51M	0.0%	+368.6%	0.056%
11/15/2022	BVF Inc. IL	4,339,521	$97.08M	4.0%	-1.0%	3.590%
11/15/2022	Bank of New York Mellon Corp	342,252	$7.66M	0.0%	+15.0%	0.283%
11/15/2022	Bellevue Group AG	4,204,820	$94.06M	1.3%	+4.3%	3.478%
11/15/2022	BlackRock Inc.	6,757,637	$151.17M	0.0%	+2.7%	5.590%
11/15/2022	Boxer Capital LLC	2,169,132	$48.52M	2.7%	-18.7%	1.794%
11/15/2022	Caas Capital Management LP	109,598	$2.45M	0.1%	N/A	0.091%
11/14/2022	Royal Bank of Canada	1,287	$29K	0.0%	+198.6%	0.001%
11/14/2022	Point72 Hong Kong Ltd	3,624	$81K	0.0%	N/A	0.003%
11/14/2022	Cubist Systematic Strategies LLC	51,934	$1.16M	0.0%	-12.3%	0.043%
11/14/2022	PDT Partners LLC	13,953	$0.31M	0.0%	-87.7%	0.012%
11/14/2022	RA Capital Management L.P.	717,618	$16.05M	0.3%	+30.7%	0.594%
11/14/2022	Third Point LLC	100,000	$2.24M	0.0%	N/A	0.083%
11/14/2022	HBK Investments L P	15,000	$0.34M	0.0%	N/A	0.012%
11/14/2022	Nuveen Asset Management LLC	274,178	$6.13M	0.0%	+1.6%	0.227%
11/14/2022	Integral Health Asset Management LLC	600,000	$13.42M	2.6%	+37.5%	0.496%
11/14/2022	MetLife Investment Management LLC	40,817	$0.91M	0.0%	+7.5%	0.034%
11/14/2022	E Fund Management Co. Ltd.	13,483	$0.30M	0.0%	-34.1%	0.011%
11/10/2022	Credit Suisse AG	64,508	$1.44M	0.0%	+11.2%	0.053%
11/10/2022	Dimensional Fund Advisors LP	635,607	$14.22M	0.0%	+61.4%	0.526%
11/10/2022	Tower Research Capital LLC TRC	9,161	$0.21M	0.0%	-39.7%	0.008%
11/10/2022	UBS Group AG	20,426	$0.46M	0.0%	-68.4%	0.017%
11/10/2022	Artisan Partners Limited Partnership	305,626	$6.84M	0.0%	+0.6%	0.253%

Data available starting January 2016

Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhibitor of fibroblast growth factor receptor 2 (FGFR2), which is in a first-in-human clinical trial for patients with advanced or metastatic FGFR2-altered solid tumors; RLY-2608, a lead mutant-PI3Ka inhibitor program that targets phosphoinostide 3 kinase alpha; and RLY-1971, an oral small molecule inhibitor of protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2 that is in Phase 1 trial in patients with advanced solid tumors. It has collaboration and license agreements with D. E. Shaw Research, LLC to research certain biological targets through the use of D. E. Shaw Research computational modeling capabilities focused on analysis of protein motion to develop and commercialize compounds and products directed to such targets; and Genentech, Inc. for the development and commercialization of RLY-1971. The company was formerly known as Allostery, Inc. and changed its name to Relay Therapeutics, Inc. in December 2015. Relay Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $15.31

$14.82

$15.48

50 Day Range

MA: $18.41

$15.21

$22.76

52 Week Range

Now: $15.31

$12.65

$35.36

Volume

1,384,699 shs

Average Volume

1,071,825 shs

Market Capitalization

$1.86 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Who are the company insiders with the largest holdings of Relay Therapeutics?: Relay Therapeutics' top insider shareholders include:
Mark Murcko (Director)
Sanjiv Patel (CEO)
Peter Rahmer (Insider)
Thomas Catinazzo (CFO)
Donald A Bergstrom (Insider)
Brian Adams (Insider)
Andy Porter (Insider)
Thomas Catinazzo (SVP)
Brian Adams (General Counsel)
Learn More about top insider investors at Relay Therapeutics.
Who are the major institutional investors of Relay Therapeutics?: Relay Therapeutics' top institutional shareholders include:
Price T Rowe Associates Inc. MD — 3.72%
JPMorgan Chase & Co. — 3.70%
ArrowMark Colorado Holdings LLC — 2.22%
Morgan Stanley — 1.96%
T. Rowe Price Investment Management Inc. — 1.66%
Norges Bank — 1.48%
Learn More about top institutional investors of Relay Therapeutics stock.
Which institutional investors are selling Relay Therapeutics stock?: Within the last quarter, RLAY stock was sold by these institutional investors:
Driehaus Capital Management LLC
JPMorgan Chase & Co.
Deutsche Bank AG
Price T Rowe Associates Inc. MD
First Trust Advisors LP
Gilder Gagnon Howe & Co. LLC
Squarepoint Ops LLC
Victory Capital Management Inc.
During the previous year, company insiders that have sold Relay Therapeutics company stock include:
Mark Murcko (Director)
Sanjiv Patel (CEO)
Peter Rahmer (Insider)
Thomas Catinazzo (CFO)
Donald A Bergstrom (Insider)
Brian Adams (Insider)
Andy Porter (Insider)
Learn More investors selling Relay Therapeutics stock.
Which institutional investors are buying Relay Therapeutics stock?: Within the last quarter, RLAY stock was bought by institutional investors including:
Morgan Stanley
Norges Bank
Finepoint Capital LP
Dimensional Fund Advisors LP
Alliancebernstein L.P.
UBS Group AG
Bank of America Corp DE
Rhenman & Partners Asset Management AB

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

RLAY Insider Trading

Relay Therapeutics Insider Trading History Chart

Relay Therapeutics Share Price & Price History

Relay Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Relay Therapeutics (NASDAQ:RLAY)

Institutional Buying and Selling by Quarter

Relay Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Relay Therapeutics?

Who are the major institutional investors of Relay Therapeutics?

Which institutional investors are selling Relay Therapeutics stock?

Which institutional investors are buying Relay Therapeutics stock?